Ligand validation:8EY5

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 8EY5 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8EY5_MYR_A_1009	50%	71%	0.194	0.945	0.6	0.49	-	-	1	0	100%	1
8EY5_MYR_A_1003	49%	71%	0.22	0.968	0.57	0.52	-	-	0	0	100%	1
8EY5_MYR_A_1007	31%	70%	0.251	0.92	0.61	0.52	-	-	0	0	100%	1
8EY5_MYR_A_1001	21%	72%	0.29	0.899	0.57	0.51	-	-	0	0	100%	1
8EY5_MYR_A_1010	18%	69%	0.247	0.868	0.58	0.61	-	-	1	0	81%	0.8125
8EY5_MYR_A_1005	17%	72%	0.334	0.913	0.54	0.52	-	-	1	0	100%	0.9
8EY5_MYR_A_1004	12%	72%	0.317	0.846	0.52	0.55	-	-	0	0	100%	1
8EY5_MYR_A_1008	10%	71%	0.34	0.845	0.58	0.53	-	-	4	0	100%	1
8EY5_MYR_A_1006	8%	72%	0.378	0.863	0.57	0.51	-	-	0	0	100%	1
3UIV_MYR_H_1003	71%	53%	0.096	0.951	0.64	1.15	-	1	0	0	81%	0.8125
2BXL_MYR_A_1005	65%	57%	0.13	0.931	0.64	0.97	-	1	1	0	100%	1
1E7G_MYR_A_1004	62%	55%	0.11	0.937	0.77	0.97	-	1	0	0	81%	0.8125
3SQJ_MYR_A_1006	62%	54%	0.133	0.926	0.54	1.21	-	2	1	0	100%	1
1HK4_MYR_A_1003	58%	54%	0.159	0.973	0.67	1.09	-	1	1	0	81%	0.8125
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
7OWU_MYR_C_101	84%	68%	0.106	0.967	0.53	0.66	-	-	1	0	100%	0.9375
5O9U_MYR_C_101	81%	63%	0.111	0.964	0.58	0.8	-	-	0	0	100%	0.9375
7A9Y_MYR_BBB_201	74%	66%	0.089	0.919	0.79	0.49	1	-	1	0	100%	1
5UR9_MYR_A_205	73%	56%	0.12	0.948	0.65	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.